Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kropp

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Immunology, Immunotherapy : CII|February 23, 2018
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cellsDaniela Dörfel, Christian J Lechner, Simone Joas, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Nature Cancer|October 23, 2025
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapyMaria Caterina Rotiroti, Aidan M Tousley, Hoyin Chu, et al.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A post-translational regulatory map of chronic antigen-driven human T cell dysfunctionHiroyuki Kojima, Charlotte R Wayne, Luis F Somarribas Patterson, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibilityCharles Ng, Tak Shun Fung, Dayi Li, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Immunology, Immunotherapy : CII|February 23, 2018
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cellsDaniela Dörfel, Christian J Lechner, Simone Joas, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Nature Cancer|October 23, 2025
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapyMaria Caterina Rotiroti, Aidan M Tousley, Hoyin Chu, et al.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A post-translational regulatory map of chronic antigen-driven human T cell dysfunctionHiroyuki Kojima, Charlotte R Wayne, Luis F Somarribas Patterson, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Mitochondrial ATP production promotes T cell differentiation and function by regulating chromatin accessibilityCharles Ng, Tak Shun Fung, Dayi Li, et al.
Pageof 2